podophyllotoxin has been researched along with Leukemia L 1210 in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 41 (70.69) | 18.7374 |
1990's | 12 (20.69) | 18.2507 |
2000's | 5 (8.62) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hansch, C; Khwaja, TA; Selassie, CD | 1 |
Jurd, L; Narayanan, VL; Paull, KD | 1 |
Chang, JJ; Hamel, E; Juang, JP; Kuo, SC; Lednicer, D; Lee, HZ; Lin, CM; Lin, YT; Paull, KD; Wu, TS | 1 |
Daley, L; Demerseman, P; Etiévant, C; Guminski, Y; Hill, BT; Imbert, T; Kruczynski, A; Monneret, C | 1 |
Annereau, JP; Bailly, C; Barret, JM; Brel, V; Delcros, JG; Guilbaud, N; Guminski, Y; Imbert, T; Kruczynski, A; Lansiaux, A; Vispé, S | 1 |
Arimondo, P; Bertounesque, E; Magiatis, P; Monneret, C; Roulland, E | 1 |
Chen, XH; He, Y; Ma, WY; Zhang, CN | 1 |
Arimondo, PB; Dauzonne, D; Duca, M; Léonce, S; Monneret, C; Pfeiffer, B; Pierré, A | 1 |
Glisson, B; Liu, L; Ross, W; Rowe, T; Yalowich, J | 1 |
Glisson, BS; Hande, KR; Ross, WE; Wozniak, AJ | 1 |
Glisson, BS; Ross, WE; Smallwood, SE | 1 |
Lee, T; Roberts, D | 2 |
Ross, WE; Yalowich, JC | 2 |
Ross, WE; Wozniak, AJ | 1 |
Jardine, I; Kozlowski, J; Strife, RJ | 1 |
Hilliard, S; Karas, JG; Peck, C; Roberts, D | 1 |
Hacker, M; Jackson, CW; Roberts, D | 1 |
Hilliard, S; Peck, C; Roberts, D | 1 |
Chen, XH; Ma, WY; Wang, TD; Wang, ZG; Yin, SF; Zhang, CN | 1 |
Chen, XH; Ma, WY; Wang, TD; Wang, ZG; Yin, SF; Zhang, CN; Zhuang, W | 1 |
Chen, XH; Ma, WY; Wang, TD; Yin, SF; Zhang, CN | 1 |
Li, BS; Ma, WY; Wang, ZG; Yin, SF; Zhang, CN | 1 |
Fujimoto, K; Kobunai, T; Nomura, M; Shibata, J; Sugimoto, Y; Terada, T; Wierzba, K; Yamada, Y; Yamashita, J; Yamazaki, R | 1 |
Jia, ZP; Wang, R; Xie, JW; Xu, LT | 1 |
Couture, A; Deniau, E; Grandclaudon, P; Lebrun, S; Léonce, S; Pfeiffer, B; Renard, P | 1 |
Chen, Y; Lu, K | 1 |
Allen, LM | 1 |
Coulter, D; Kalish, R; Valeriote, FA; Vietti, TJ | 1 |
Allen, L | 1 |
Hacker, M; Roberts, D | 1 |
Dombernowsky, P; Nissen, NI | 2 |
Stähelin, H | 2 |
Avery, T; Rivera, G; Roberts, DW | 1 |
Li, BS; Ma, WY; Wang, ZG; Zhang, CN | 1 |
Lee, BS; Ma, WY; Wang, ZG; Yin, SF; Zhang, CN; Zhuang, W | 1 |
Gorin, NC | 1 |
Beerman, TA; Sigmund, RD; Woynarowski, JM | 2 |
Foglesong, PD; Parganas, E; Roberts, DW; Wiggins, L | 1 |
Ellis, AL; Gewirtz, DA; Povirk, LF; Randolph, JK; Swerdlow, PS; Yalowich, JC; Yanovich, S | 1 |
Kupfer, G; Ross, W; Rowe, T | 1 |
Glisson, BS; Hodges, PK; Ross, WE; Smallwood-Kentro, S; Sullivan, DM | 1 |
Dorr, RT; Gerner, EW; Liddil, JD | 1 |
Kerrigan, D; Kohn, KW; Pommier, Y | 1 |
Chu, PS; Dempcy, RO; Hamel, E; Lin, CM; Pettit, GR; Schmidt, JM; Singh, SB | 1 |
Murray, SL; Slater, LM; Stupecky, M; Sweet, P; Wetzel, MW | 1 |
Ishikura, H; Izumi, Y; Mochizuki, T; Okazaki, T; Sasada, M; Sawada, H; Tashima, M; Uchino, H | 1 |
Ashmun, R; Lee, T; Parganas, E; Roberts, D; Wiggins, L; Yalowich, J | 1 |
Kondo, S; Nishimura, Y; Saito, H; Takeuchi, T; Umezawa, H; Yoshikawa, H | 2 |
Ishikura, H; Izumi, Y; Mochizuki, T; Okazaki, T; Sawada, H; Tashima, M; Uchino, H; Usui, T | 1 |
Kuramochi, H; Nagamine, S; Nishikawa, K; Okamoto, K; Takahashi, K | 1 |
Herrmann, R; Osswald, H; Youssef, M | 1 |
Avery, TL; Price, RA; Roberts, D | 1 |
1 trial(s) available for podophyllotoxin and Leukemia L 1210
Article | Year |
---|---|
VP-16: phase specific cytocidal activity and preliminary trials in acute monocytic leukemias.
Topics: Animals; Cell Cycle; Clinical Trials as Topic; DNA, Neoplasm; Humans; Interphase; Leukemia L1210; Leukemia, Monocytic, Acute; Male; Mice; Middle Aged; Podophyllotoxin | 1986 |
57 other study(ies) available for podophyllotoxin and Leukemia L 1210
Article | Year |
---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
In vivo antitumor activity of 6-benzyl-1,3-benzodioxole derivatives against the P388, L1210, B16, and M5076 murine models.
Topics: Animals; Antineoplastic Agents; Astrocytoma; Bucladesine; Cell Differentiation; Dioxoles; DNA Topoisomerases, Type I; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mice; Tubulin | 1987 |
Synthesis and cytotoxicity of 1,6,7,8-substituted 2-(4'-substituted phenyl)-4-quinolones and related compounds: identification as antimitotic agents interacting with tubulin.
Topics: Animals; Antineoplastic Agents; Humans; Intestinal Neoplasms; Leukemia L1210; Leukemia P388; Lung Neoplasms; Melanoma; Mice; Molecular Structure; Nasopharyngeal Neoplasms; Quinolines; Quinolones; Software; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Tumor Cells, Cultured | 1993 |
Synthesis and antitumor activity of new glycosides of epipodophyllotoxin, analogues of etoposide, and NK 611.
Topics: Animals; Antineoplastic Agents; Biopolymers; Drug Screening Assays, Antitumor; Female; Glycosides; Glycosylation; Humans; Inhibitory Concentration 50; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred DBA; Podophyllotoxin; Stereoisomerism; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transplantation, Heterologous; Tubulin; Tumor Cells, Cultured | 1998 |
F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.
Topics: Animals; Binding, Competitive; Biogenic Polyamines; Breast Neoplasms; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Delivery Systems; Etoposide; Female; Humans; Leukemia L1210; Lung Neoplasms; Mice; Mice, Nude; Neoplasms; Podophyllotoxin; Topoisomerase II Inhibitors; Xenograft Model Antitumor Assays | 2008 |
Hemi-synthesis and biological activity of new analogues of podophyllotoxin.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Enzyme Inhibitors; Humans; Leukemia L1210; Necrosis; Podophyllotoxin; Stereoisomerism; Structure-Activity Relationship; Swine; Topoisomerase I Inhibitors; Tubulin | 2002 |
[Synthesis and activities of 4-deoxy-4 beta-arylmehtylene sulfonylamido-4'-demethylpodophyllotoxins].
Topics: Animals; Antineoplastic Agents, Phytogenic; Humans; KB Cells; Leukemia L1210; Molecular Structure; Podophyllotoxin; Structure-Activity Relationship; Tumor Cells, Cultured | 2001 |
Novel carbamate derivatives of 4-beta-amino-4'-O-demethyl-4-desoxypodophyllotoxin as inhibitors of topoisomerase II: synthesis and biological evaluation.
Topics: Animals; Antineoplastic Agents; Carbamates; Cell Division; DNA; DNA Damage; Enzyme Inhibitors; Etoposide; G2 Phase; Leukemia L1210; Mice; Molecular Structure; Podophyllotoxin; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2005 |
Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.
Topics: Animals; Cattle; Cell Nucleus; Cell Survival; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Leukemia L1210; Mice; Podophyllotoxin; Structure-Activity Relationship; Teniposide; Thymus Gland | 1984 |
Inhibition of etoposide-induced DNA damage and cytotoxicity in L1210 cells by dehydrogenase inhibitors and other agents.
Topics: Aldehyde Dehydrogenase; Aldehyde Oxidoreductases; Animals; Benzoates; Benzoic Acid; Cell Survival; Disulfiram; Ditiocarb; DNA; Etoposide; Leukemia L1210; Mice; NADP; Podophyllotoxin; Thiocarbamates | 1984 |
Characterization of VP-16-induced DNA damage in isolated nuclei from L1210 cells.
Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Animals; DNA; Etoposide; Hydrogen-Ion Concentration; Leukemia L1210; Magnesium; Mice; Nucleotides; Podophyllotoxin; Temperature | 1984 |
Flux of teniposide (VM-26) across the plasma membrane of teniposide-resistant sublines of L1210 cells.
Topics: Animals; Biological Transport; Cell Membrane; Drug Resistance; Kinetics; Leukemia L1210; Mice; Mutation; Podophyllotoxin; Teniposide | 1984 |
Selection and characterization of L1210 sublines resistant to teniposide (VM-26).
Topics: Animals; Cell Division; Chromosome Banding; Clone Cells; Drug Resistance; Karyotyping; Kinetics; Leukemia L1210; Metaphase; Mice; Mutation; Podophyllotoxin; Teniposide | 1984 |
Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro.
Topics: Animals; Cell Division; Cell Nucleus; Cell Survival; DNA Replication; DNA, Neoplasm; Drug Synergism; Etoposide; Gallopamil; Kinetics; Leukemia L1210; Mice; Podophyllotoxin; Verapamil | 1984 |
DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity.
Topics: Animals; Chemical Phenomena; Chemistry; Colony-Forming Units Assay; DNA; DNA, Single-Stranded; Dose-Response Relationship, Drug; Etoposide; Leukemia L1210; Mice; Podophyllotoxin | 1983 |
Synthesis, 470-MHz 1H NMR spectra, and activity of delactonized derivatives of the anticancer drug etoposide.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Etoposide; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Podophyllotoxin | 1982 |
Response of L1210 leukemia to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea plus 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside).
Topics: Animals; Carmustine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Etoposide; Female; Leukemia L1210; Mice; Mice, Inbred Strains; Podophyllotoxin; Prognosis | 1981 |
Effect of VM-26 on the haematological responses of mice to L1210 leukaemia.
Topics: Animals; Female; Hematocrit; Leukemia L1210; Leukocyte Count; Mice; Neoplasm Transplantation; Platelet Count; Podophyllotoxin; Teniposide; Transplantation, Homologous | 1980 |
Sedimentation of DNA from L1210 cells after treatment with 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) or 1-beta-D-arabinofuranosylcytosine or both drugs.
Topics: Animals; Antibiotics, Antineoplastic; Centrifugation, Density Gradient; Cytarabine; Dose-Response Relationship, Drug; Drug Interactions; Leukemia L1210; Mice; Podophyllotoxin; Teniposide; Time Factors | 1980 |
[Synthesis and antitumor activity of 4-O-(halogenated) acyl-4'-demethylepipodophyllotoxin analogues].
Topics: Animals; Etoposide; Humans; KB Cells; Leukemia L1210; Mice; Podophyllotoxin; Tumor Cells, Cultured | 1993 |
[Synthesis and antitumor activity of 4-S-(5-amido-1,3,4-thiodiazol-2-yl)4-deoxy-4'-demethylepipodophyllotoxi n analogues].
Topics: Animals; Etoposide; Humans; KB Cells; Leukemia L1210; Podophyllotoxin; Tumor Cells, Cultured | 1993 |
[Synthesis and antitumor activity of 4-(2-amido-2-ethoxycarbonyl) ethylsulfenyl-4-deoxy-4'-demethylepipodophyllotoxin analogues].
Topics: Animals; Antineoplastic Agents; Humans; KB Cells; Leukemia L1210; Podophyllotoxin; Tumor Cells, Cultured | 1993 |
[Synthesis and antitumor activities of 4-acylamido-4-deoxy-4'-demethylepipodophyllotoxin analogues].
Topics: Animals; Antineoplastic Agents, Phytogenic; Leukemia L1210; Molecular Structure; Podophyllotoxin; Tumor Cells, Cultured | 1993 |
Antitumor agents. 3. Synthesis and biological activity of 4 beta-alkyl derivatives containing hydroxy, amino, and amido groups of 4'-O-demethyl-4-desoxypodophyllotoxin as antitumor agents.
Topics: Animals; Antineoplastic Agents; Etoposide; Humans; Leukemia L1210; Leukemia P388; Lung Neoplasms; Molecular Structure; Podophyllotoxin; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tubulin Modulators; Tumor Cells, Cultured | 1993 |
Action of free radical in podophyllic acid piperindyl hydrazone nitroxide radical on its antitumor activity and toxicity.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; DNA, Neoplasm; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mitotic Index; Neoplasm Transplantation; Neoplasms, Experimental; Podophyllotoxin; Stomach Neoplasms; Tumor Cells, Cultured | 1999 |
First synthesis and pharmacological evaluation of benzoindolizidine and benzoquinolizidine analogues of alpha- and beta-peltatin.
Topics: Animals; Antineoplastic Agents; Cell Cycle; DNA; Drug Screening Assays, Antitumor; Indolizines; Leukemia L1210; Mice; Molecular Structure; Podophyllotoxin; Quinolizines | 2000 |
[Synthesis of spin labeled analogue of podophyllotoxin glycoside].
Topics: Animals; Antineoplastic Agents, Phytogenic; Leukemia L1210; Mice; Podophyllotoxin; Spin Labels; Tumor Cells, Cultured | 1998 |
Comparison of uptake and binding of two epipodophyllotoxin glucopyranosides, 4'-demethyl epipodophyllotoxin thenylidene-beta-D-glucoside and 4'-demethyl epipodophyllotoxin ethylidene-beta-D-glucoside, in the L1210 leukemia cell.
Topics: Animals; Binding Sites; Biological Transport; Cell Nucleus; Etoposide; Kinetics; Leukemia L1210; Mice; Mice, Inbred DBA; Podophyllotoxin; Teniposide; Thermodynamics; Vinblastine | 1978 |
Kinetics of cytotoxicity of VM-26 and VP-16-213 on L1210 leukemia and hematopoietic stem cells.
Topics: Animals; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Etoposide; Hematopoietic Stem Cells; Leukemia L1210; Podophyllotoxin; Rats; Teniposide; Time Factors | 1978 |
The role of drug disposition kinetics on cellular transport of the antineoplastic agent VM-26.
Topics: Animals; Biological Transport, Active; Chemical Phenomena; Chemistry; Diffusion; Etoposide; Kinetics; Leukemia L1210; Mice; Models, Biological; Podophyllotoxin; Protein Binding; Serum Albumin; Teniposide | 1978 |
VM26-induced changes in hepatic intermediary metabolism of mice.
Topics: Animals; Blood Glucose; Doxorubicin; Drug Synergism; Female; Glucose; Hexosephosphates; In Vitro Techniques; Isocitrates; Ketoglutaric Acids; Leukemia L1210; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mitochondria, Liver; Oxygen Consumption; Podophyllotoxin; Succinates; Teniposide | 1977 |
Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia.
Topics: Animals; Antineoplastic Agents; Carmustine; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Leukemia L1210; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred DBA; Podophyllotoxin; Vincristine | 1976 |
Delayed toxicity of epipodophyllotoxin derivatives (VM 26 and VP 16-213), due to a local effect.
Topics: Animals; Dose-Response Relationship, Drug; Etoposide; Female; Injections, Intraperitoneal; Injections, Intravenous; Leukemia L1210; Liver; Lung; Male; Mice; Organ Size; Podophyllotoxin; Rats; Teniposide; Time Factors | 1976 |
Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.
Topics: Animals; Cytarabine; Drug Therapy, Combination; Etoposide; Female; Leukemia L1210; Leukemia, Experimental; Mice; Podophyllotoxin; Pyrans; Teniposide | 1975 |
[Synthesis and antitumor activity of 4-alkylthio-4-deoxy-4'-demethylepipodophyllotxin derivatives].
Topics: Animals; Antineoplastic Agents; Humans; KB Cells; Leukemia L1210; Podophyllotoxin; Tumor Cells, Cultured | 1992 |
[Synthesis and antitumor activities of 4-acylthiol-4-deoxy-4'-demethylepipodophyllotoxin analogues].
Topics: Animals; Antineoplastic Agents; Leukemia L1210; Podophyllotoxin | 1992 |
Pharmacological purging of bone marrow with drugs other than cyclophosphamide derivatives.
Topics: Animals; Antineoplastic Agents; Bleomycin; Bone Marrow; Cell Line; Cell Separation; Etoposide; Hematopoietic Stem Cells; Leukemia L1210; Leukemia, Experimental; Mice; Mice, Inbred C57BL; Podophyllotoxin | 1985 |
DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells.
Topics: Amsacrine; Animals; Bisbenzimidazole; Cell Nucleus; Deoxyribonucleoproteins; Distamycins; DNA Damage; DNA, Neoplasm; Indoles; Kinetics; Leukemia L1210; Mice; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors | 1989 |
Reduced formation of lesions in the DNA of a multidrug-resistant L1210 subline selected for teniposide resistance.
Topics: Animals; DNA; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Leukemia L1210; Podophyllotoxin; Potassium Cyanide; Teniposide; Tumor Cells, Cultured; Verapamil | 1989 |
Expression of protein-associated DNA damage in the alkaline elution assay in the absence of enzymatic deproteinization.
Topics: Animals; Cell Line; DNA Damage; DNA Replication; DNA Topoisomerases, Type II; DNA, Neoplasm; Endopeptidase K; Etoposide; Humans; Hydrogen-Ion Concentration; Leukemia L1210; Liver Neoplasms, Experimental; Mice; Mitoxantrone; Podophyllotoxin; Protein Binding; Rats; Serine Endopeptidases; Teniposide; Tumor Cells, Cultured | 1989 |
Topoisomerase-II-mediated lesions in nascent DNA: comparison of the effects of epipodophyllotoxin derivatives, VM-26 and VP-16, and 9-anilinoacridine derivatives, m-AMSA and o-AMSA.
Topics: Adenosine Triphosphate; Amsacrine; Animals; Cross-Linking Reagents; DNA; DNA Damage; DNA Replication; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Leukemia L1210; Mice; Novobiocin; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors | 1988 |
Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavage.
Topics: Animals; Cell Survival; DNA; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Ethidium; Etoposide; Leukemia L1210; Mice; Podophyllotoxin | 1985 |
Proliferation dependence of topoisomerase II mediated drug action.
Topics: Aminoacridines; Amsacrine; Animals; Cell Line; Cricetinae; Cricetulus; DNA Replication; DNA Topoisomerases, Type II; Etoposide; Female; HeLa Cells; Humans; Intercalating Agents; Kinetics; Leukemia L1210; Mice; Ovary; Plasmids; Podophyllotoxin | 1986 |
Modulation of etoposide cytotoxicity and DNA strand scission in L1210 and 8226 cells by polyamines.
Topics: Animals; Cell Survival; DNA Topoisomerases, Type II; DNA, Neoplasm; DNA, Single-Stranded; Eflornithine; Etoposide; Humans; Leukemia L1210; Mice; Multiple Myeloma; Nucleic Acid Conformation; Ornithine; Podophyllotoxin; Polyamines; Putrescine | 1986 |
Protein-linked DNA strand breaks produced by etoposide and teniposide in mouse L1210 and human VA-13 and HT-29 cell lines: relationship to cytotoxicity.
Topics: Animals; Cell Line; Cell Survival; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Humans; Kinetics; Leukemia L1210; Podophyllotoxin; Teniposide | 1987 |
Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study.
Topics: Animals; Anisoles; Antineoplastic Agents; Bibenzyls; Binding Sites; Binding, Competitive; Colchicine; Leukemia L1210; Mice; Mitosis; Podophyllotoxin; Protein Binding; Stilbenes; Structure-Activity Relationship; Tubulin | 1988 |
Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Drug Synergism; Etoposide; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Leukemia, Lymphoid; Mice; Podophyllotoxin; Verapamil; Vincristine | 1986 |
Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line; Cyanides; Drug Resistance; Leukemia L1210; Lipid Metabolism; Mice; Neoplasm Proteins; Phenotype; Podophyllotoxin; Teniposide; Verapamil | 1987 |
Studies on lignan lactone antitumor agents. I. Synthesis of aminoglycosidic lignan variants related to podophyllotoxin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Etoposide; Leukemia L1210; Mice; Podophyllotoxin | 1986 |
Studies on lignan lactone antitumor agents. II. Synthesis of N-alkylamino- and 2,6-dideoxy-2-aminoglycoside lignan variants related to podophyllotoxin.
Topics: Aminoglycosides; Animals; Antineoplastic Agents, Phytogenic; Etoposide; Leukemia L1210; Mice; Podophyllotoxin | 1986 |
Effects of VP-16 on cell growth and metabolism of nucleic acids in mouse leukemia L-1210 cells and on the activity of DNA polymerase I of E. coli.
Topics: Animals; Cell Nucleus; Cytoplasm; Dimethyl Sulfoxide; DNA; DNA Polymerase I; Escherichia coli; Leukemia L1210; Mice; Podophyllotoxin | 1985 |
Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro.
Topics: Animals; Cells, Cultured; DNA Repair; Drug Synergism; Etoposide; Leukemia L1210; Mice; Podophyllotoxin; Tritium; Verapamil | 1985 |
[Antitumor effect of etoposide and its analogs].
Topics: Animals; Cell Division; Dogs; Etoposide; HeLa Cells; Humans; Leukemia L1210; Male; Mice; Podophyllotoxin; Structure-Activity Relationship | 1985 |
Timing- and sequence-dependent synergism between etoposide and methotrexate or etoposide, methotrexate and 5-fluorouracil in advanced leukemia L1210.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Etoposide; Female; Fluorouracil; Leukemia L1210; Methotrexate; Mice; Mice, Inbred Strains; Podophyllotoxin; Time Factors | 1985 |
Delayed toxicity of 4'-demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) in mice.
Topics: Animals; Body Weight; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Female; Glycosides; Leukemia L1210; Leukemia, Experimental; Liver; Male; Mice; Mice, Inbred A; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Neoplasm Transplantation; Organ Size; Pancreas; Podophyllotoxin; Time Factors; Transplantation, Homologous | 1973 |
Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia.
Topics: Animals; Drug Evaluation, Preclinical; Female; Injections, Intraperitoneal; Leukemia L1210; Male; Mice; Neoplasm Transplantation; Podophyllotoxin; Time Factors; Transplantation, Homologous | 1973 |
4'-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of action.
Topics: Animals; Carcinoma 256, Walker; Culture Techniques; Female; Fibroblasts; Leukemia L1210; Male; Mast-Cell Sarcoma; Mice; Mitosis; Neoplasms, Experimental; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Rats | 1970 |